{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:41:54Z","timestamp":1770194514907,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022716","name":"Swiss Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.euros.2025.12.009","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T13:06:49Z","timestamp":1767100009000},"page":"198-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of Socioeconomic Position, Prostate-specific Antigen, and Age with Observation in Low-risk Prostate Cancer Patients in Switzerland"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5544-1063","authenticated-orcid":false,"given":"Thomas Paul","family":"Scherer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Menges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Bieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea","family":"Wildisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Staehelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian Alexander","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basil","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Eberli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Rohrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric","family":"Poyet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2025.12.009_b0005","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.juro.2015.01.126","article-title":"Gleason 6 prostate cancer: translating biology into population health","volume":"194","author":"Eggener","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2025.12.009_b0010","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/PAS.0b013e3182556dcd","article-title":"Do adenocarcinomas of the prostate with Gleason score (GS)\u22646 have the potential to metastasize to lymph nodes?","volume":"36","author":"Ross","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euros.2025.12.009_b0015","series-title":"EAU - EANM - ESTRO - ESUR - ISUP - SIOG guidelines on prostate cancer","author":"Cornford","year":"2024"},{"key":"10.1016\/j.euros.2025.12.009_b0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.6004\/jnccn.2021.0008","article-title":"Prostate cancer, version 1.2021: featured updates to the NCCN guidelines","volume":"19","author":"Schaeffer","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.euros.2025.12.009_b0025","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.juro.2018.01.002","article-title":"Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline. Part II: recommended approaches and details of specific care options","volume":"199","author":"Sanda","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2025.12.009_b0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.31349","article-title":"Regional variation in active surveillance for low-risk prostate cancer in the US","volume":"3","author":"Washington","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euros.2025.12.009_b0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cncr.30983","article-title":"Variation in the use of active surveillance for low-risk prostate cancer","volume":"124","author":"L\u00f6ppenberg","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.euros.2025.12.009_b0040","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jamaoncol.2016.3600","article-title":"Uptake of active surveillance for very-low-risk prostate cancer in Sweden","volume":"3","author":"Loeb","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euros.2025.12.009_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.644885","article-title":"Variation in the use of active surveillance for low-risk prostate cancer across US Census regions","volume":"11","author":"Al Hussein Al Awamlh","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.euros.2025.12.009_b0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2010.30.2075","article-title":"Impact of age at diagnosis on prostate cancer treatment and survival","volume":"29","author":"Bechis","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2025.12.009_b0055","doi-asserted-by":"crossref","first-page":"40103","DOI":"10.57187\/smw.2023.40103","article-title":"Retrospective analysis of the uptake of active surveillance for low-risk prostate cancer in Zurich, Switzerland","volume":"153","author":"Poyet","year":"2023","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.euros.2025.12.009_b0060","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euros.2025.12.009_b0065","doi-asserted-by":"crossref","first-page":"40028","DOI":"10.57187\/smw.2023.40028","article-title":"The Swiss neighbourhood index of socioeconomic position: update and re-validation","volume":"153","author":"Panczak","year":"2023","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.euros.2025.12.009_b0070","unstructured":"Federal Statistical Office. Generalisierte Grenzen 2020: Hilfsdatei. 2020. https:\/\/dam-api.bfs.admin.ch\/hub\/api\/dam\/assets\/14776427\/master."},{"key":"10.1016\/j.euros.2025.12.009_b0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0210-4806(09)74110-5","article-title":"EAU guidelines on prostate cancer","volume":"33","author":"Heidenreich","year":"2009","journal-title":"Acta Urol Esp"},{"key":"10.1016\/j.euros.2025.12.009_b0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2025.12.009_b0085","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.eururo.2019.03.041","article-title":"Re: Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States 2010\u20132015","volume":"76","author":"Werntz","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.009_b0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41391-019-0175-9","article-title":"United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015","volume":"23","author":"Butler","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euros.2025.12.009_b0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.urology.2021.01.053","article-title":"Influence of sociodemographic factors on definitive intervention among low-risk active surveillance patients","volume":"155","author":"Sayyid","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.euros.2025.12.009_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2022.102164","article-title":"Socioeconomic differences in prostate cancer treatment: A systematic review and meta-analysis","volume":"79","author":"Gallagher","year":"2022","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.euros.2025.12.009_b0105","unstructured":"European Observatory on Health Systems and Policies. United Kingdom: health system review 2022. https:\/\/eurohealthobservatory.who.int\/publications\/i\/united-kingdom-health-system-review-2022."},{"key":"10.1016\/j.euros.2025.12.009_b0110","unstructured":"European Observatory on Health Systems and Policies. Sweden: health system review 2023. https:\/\/eurohealthobservatory.who.int\/publications\/i\/sweden-health-system-review-2023."},{"key":"10.1016\/j.euros.2025.12.009_b0115","unstructured":"World Health Organization. Health systems in transition: Canada. https:\/\/iris.who.int\/handle\/10665\/107681."},{"key":"10.1016\/j.euros.2025.12.009_b0120","unstructured":"World Health Organization. Health care systems in transition: Australia. https:\/\/iris.who.int\/handle\/10665\/108466."},{"key":"10.1016\/j.euros.2025.12.009_b0125","first-page":"1","article-title":"Switzerland. Health system review","volume":"17","author":"De Pietro","year":"2015","journal-title":"Health Syst Transmit"},{"key":"10.1016\/j.euros.2025.12.009_b0130","unstructured":"Rice T, Rosenau P, Unruh LY, Barnes AJ. Health systems in transition: United States Health system review. 2020. www.healthobservatory.eu."},{"key":"10.1016\/j.euros.2025.12.009_b0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00345-016-1897-0","article-title":"Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional study","volume":"35","author":"Timilshina","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.euros.2025.12.009_b0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.euo.2019.04.006","article-title":"Trends in conservative management for low-risk prostate cancer in a population-based cohort of Australian men diagnosed between 2009 and 2016","volume":"4","author":"Ong","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2025.12.009_b0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.eururo.2017.08.001","article-title":"Urologist practice affiliation and intensity-modulated radiation therapy for prostate cancer in the elderly","volume":"73","author":"Hollenbeck","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.009_b0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.53658","article-title":"Physician payment incentives and active surveillance in low-risk prostate cancer","volume":"8","author":"Srivastava","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euros.2025.12.009_b0155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eururo.2018.02.026","article-title":"Factors influencing men\u2019s choice of and adherence to active surveillance for low-risk prostate cancer: a mixed-method systematic review","volume":"74","author":"Kinsella","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.009_b0160","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.juro.2017.11.067","volume":"199","author":"Hassan","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2025.12.009_b0165","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.38039","article-title":"Patient and context factors in the adoption of active surveillance for low-risk prostate cancer","volume":"6","author":"Ciccone","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euros.2025.12.009_b0170","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.eururo.2012.11.005","article-title":"Active surveillance for low-risk prostate cancer worldwide: the PRIAS study","volume":"63","author":"Bul","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.009_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euros.2025.01.004","article-title":"Impact of prebiopsy multiparametric magnetic resonance imaging on prostate cancer detection in Switzerland","volume":"73","author":"Scherer","year":"2025","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2025.12.009_b0180","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1200\/JCO.2016.68.0058","article-title":"Active surveillance in younger men with prostate cancer","volume":"35","author":"Leapman","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2025.12.009_b0185","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.eururo.2014.10.010","article-title":"Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification","volume":"67","author":"Loeb","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.009_b0190","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.juro.2014.02.045","article-title":"Age and baseline quality of life at radical prostatectomy\u2014who has the most to lose?","volume":"192","author":"Brajtbord","year":"2014","journal-title":"J Urol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168325024851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168325024851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T21:09:29Z","timestamp":1770152969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168325024851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"alternative-id":["S2666168325024851"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2025.12.009","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Socioeconomic Position, Prostate-specific Antigen, and Age with Observation in Low-risk Prostate Cancer Patients in Switzerland","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2025.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}